both engaging for the readership and foster further collaboration in the science and clinical practice of radiation oncology. All 3DCRT debates thus far have included a radiation oncologist, medical physicist, and radiobiologist on each team. For this debate, we break that trend and include a patient representative along with a radiation oncologist and medical physicist on each team. We hope this patient perspective adds a valuable new aspect to our debate format and encourages the continued inclusion of patient perspectives in future clinical discussions.